Previous close | 46.72 |
Open | 47.00 |
Bid | 46.66 x 100 |
Ask | 46.81 x 100 |
Day's range | 46.50 - 47.46 |
52-week range | 32.69 - 52.69 |
Volume | |
Avg. volume | 110,259 |
Market cap | 933.295M |
Beta (5Y monthly) | 0.71 |
PE ratio (TTM) | 89.81 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.24 (0.51%) |
Ex-dividend date | 26 Apr 2024 |
1y target est | N/A |
LANCASTER, Calif., April 04, 2024--Simulations Plus announced the US FDA has again renewed licenses to its DILIsym QST software to support informed decision-making in drug approvals.
LANCASTER, Calif., April 03, 2024--Simulations Plus today reported earnings for its second quarter of fiscal year 2024. Total revenue for the quarter increased 16% to $18.3 million.
LANCASTER, Calif., March 20, 2024--Simulations Plus will hold a conference call to discuss the Company's 2nd quarter FY24 financial results on Wed, April 3, 2024, at 5pm EDT.